Division of Basic and Clinical Immunology, University of California at Irvine, Irvine, California, USA.
Division of Basic and Clinical Immunology, University of California at Irvine, Irvine, California, USA,
Int Arch Allergy Immunol. 2021;182(3):243-253. doi: 10.1159/000510790. Epub 2020 Oct 14.
Immunoglobulin (Ig) therapy reduces the frequency and severity of infection among patients with antibody deficiency disorders. However, a subset of patients lacks adequate clinical response.
The purpose of this study was to determine in adult common variable immune deficiency (CVID) patients (A) if lack of clinical response to Ig therapy correlates with lack of reconstitution of IgG subclass (es), (B) correlation between Ig dosing and/or IgG trough levels and IgG subclass reconstitution, (C) and most common impaired Streptococcus pneumoniae (S. pneumoniae) serotype antibody response.
Single-institution, retrospective chart review for CVID patients at immunology clinics from 2015 to 2019. Patients were monitored every 3-6 months for IgG dosage, IgG trough levels, IgG subclass reconstitution, infectious episodes (chronic sinusitis, bronchitis, upper respiratory, and lower respiratory tract infections), urinary tract infections, and antibiotic use. Follow-up was calculated in patient years.
Twenty-five of 41 patients achieved complete reconstitution of all IgG subclasses, and 16/41 demonstrated intermittent or lack of reconstitution. There were significantly less (p < 0.001) infections among fully reconstituted patients (0.66 ± 0.19 infections per patient year) as compared to those with intermittent or lack of reconstitution (1.26 ± 0.13 infections per patient year). There was a significant correlation between IgG trough levels and IgG subclass reconstitution. Most common impaired S. pneumoniae serotype included 3, 4, 9n, 10a, 11a, 12f, and 15b.
Incomplete IgG subclass reconstitution was associated with increased frequency of infections. IgG trough levels correlate with IgG subclass reconstitution. A limited number of S. pneumoniae serotype antibodies are commonly impaired in CVID.
免疫球蛋白(Ig)治疗可降低抗体缺陷疾病患者感染的频率和严重程度。然而,一部分患者缺乏充分的临床反应。
本研究旨在确定成人普通可变免疫缺陷(CVID)患者中:(A)Ig 治疗无临床反应是否与 IgG 亚类(es)重建缺乏相关,(B)Ig 剂量和/或 IgG 谷值与 IgG 亚类重建之间的相关性,(C)最常见的肺炎链球菌(S. pneumoniae)血清型抗体反应受损。
对 2015 年至 2019 年免疫诊所的 CVID 患者进行单机构回顾性图表审查。每 3-6 个月监测患者 IgG 剂量、IgG 谷值、IgG 亚类重建、感染发作(慢性鼻窦炎、支气管炎、上呼吸道和下呼吸道感染)、尿路感染和抗生素使用情况。随访以患者年计算。
41 例患者中有 25 例完全重建了所有 IgG 亚类,16/41 例间歇性或缺乏重建。完全重建患者的感染次数明显较少(p <0.001)(每位患者每年 0.66 ± 0.19 次感染),而间歇性或缺乏重建患者的感染次数较多(每位患者每年 1.26 ± 0.13 次感染)。IgG 谷值与 IgG 亚类重建呈显著相关。最常见的受损 S. pneumoniae 血清型包括 3、4、9n、10a、11a、12f 和 15b。
不完全 IgG 亚类重建与感染频率增加相关。IgG 谷值与 IgG 亚类重建相关。CVID 中常见的少数几种 S. pneumoniae 血清型抗体受损。